Back to Search
ALPINIANO PINTOR, M.D.
M.D.
Internal Medicine Physician
NPI: 1962648907IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD437710(PA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 1996
Research & Publications (16)
The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum.
PMID 16895732·Neuropharmacology·2006
4-observational
Adenosine A 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors.
PMID 15030399·J Neurochem·2004
7-preclinical
SCH 58261 (an adenosine A(2A) receptor antagonist) reduces, only at low doses, K(+)-evoked glutamate release in the striatum.
PMID 11516434·Eur J Pharmacol·2001
7-preclinical
The mGlu5 receptor agonist CHPG stimulates striatal glutamate release: possible involvement of A2A receptors.
PMID 11095529·Neuroreport·2000
7-preclinical
Age-related decline in the functional response of striatal group I mGlu receptors.
PMID 11006989·Neuroreport·2000
7-preclinical
Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
PMID 18805673·Schizophr Res·2009
8-other
Behavioural and neurochemical characterization of the adenosine A2A receptor antagonist ST1535.
PMID 18036583·Eur J Pharmacol·2008
7-preclinical
Minocycline in phenotypic models of Huntington's disease.
PMID 15649711·Neurobiol Dis·2005
7-preclinical
Adenosine A2A receptor antagonism and neuroprotection: mechanisms, lights, and shadows.
PMID 15581405·Crit Rev Neurobiol·2004
6-review
Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
PMID 15197743·J Neurosci Res·2004
7-preclinical
Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activity.
PMID 15189351·J Neurochem·2004
7-preclinical
Modulation of glutamate release and excitotoxicity by adenosine A2A receptors.
PMID 14663014·Neurology·2003
7-preclinical
A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists.
PMID 12832562·J Neurosci·2003
7-preclinical
Metabotropic glutamate receptor 5 (mGluR5)-mediated phosphoinositide hydrolysis and NMDA-potentiating effects are blunted in the striatum of aged rats: a possible additional mechanism in striatal senescence.
PMID 12786971·Eur J Neurosci·2003
7-preclinical
Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.
PMID 11880527·J Neurosci·2002
7-preclinical
The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors.
PMID 11557164·Neuropsychopharmacology·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 801 OSTRUM ST
BETHLEHEM, PA 18015 - Phone
- (484) 526-6643
Quick Facts
- NPI
- 1962648907
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 16
Are you this provider?
Claim Your Profile